Advertisement

Immunogenetics

, Volume 69, Issue 6, pp 371–378 | Cite as

The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients

  • Mina Abdolahi
  • Abbas Tafakhori
  • Mansoureh Togha
  • Ali Asghar Okhovat
  • Feridoun Siassi
  • Mohammad Reza Eshraghian
  • Mohsen Sedighiyan
  • Mona Djalali
  • Niyaz Mohammadzadeh Honarvar
  • Mahmoud Djalali
Original Article

Abstract

Migraine is a destabilizing neuroinflammatory disorder characterized by recurrent headache attacks. Evidences show tumor necrosis factor (TNF)-α play a role in neuroimmunity pathogenesis of migraine. TNF-α increase prostanoid production, hyperexcitability of neurons, and nociceptor activation resulted in neuroinflammation and neurogenic pain. ω-3 fatty acids and curcumin exert neuroprotective and anti-inflammatory effects via several mechanisms including suppression of TNF-α gene expression and its serum levels. The aim of this study is an evaluation of synergistic effects of ω-3 fatty acids and nano-curcumin on TNF-α gene expression and serum levels in migraine patients. The present study performed as a clinical trial over a 2 month period included 74 episodic migraine patients in 4 groups and received ω-3 fatty acids, nano-curcumin, and combination of them or placebo. At the start and the end of the study, the gene expression of TNF-α and TNF-α serum levels was measured by real-time PCR and ELISA method, respectively. Our results showed that the combination of ω-3 fatty acids and nano-curcumin downregulated TNF-α messenger RNA (mRNA) significantly in a synergistic manner (P < 0.05). As relative to gene expression, a significant greater reduction in serum levels of TNF-α were observed in the combination group, but no significant differences in other groups. Supplementation with ω-3 fatty acids or nano-curcumin alone did not show significant reduction either in mRNA or serum levels of TNF-α. In addition, a much greater reduction in attack frequency was found in the combination group (P < 0.001). These findings indicated that ω-3 fatty acids and curcumin supplementation can be considered as a new promising approach in migraine management.

Keywords

Migraine Curcumin ω-3 fatty acids TNF-α Gene expression 

Notes

Acknowledgments

This study was approved by ethics committee of the Tehran University Medical of Sciences (TUMS). Those who participated in this study are kindly acknowledged.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Bauer I, Crewther S, Pipingas A, Sellick L, Crewther D (2014) Does omega-3 fatty acid supplementation enhance neural efficiency? A review of the literature Human Psychopharmacology: Clinical and Experimental 29:8–18CrossRefGoogle Scholar
  2. Bazan NG, Molina MF, Gordon WC (2011) Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration Alzheimer's, and other neurodegenerative diseases. Annual Review of Nutrition 31:321–351CrossRefPubMedPubMedCentralGoogle Scholar
  3. Boćkowski L, Śmigielska-Kuzia J, Sobaniec W, Żelazowska-Rutkowska B, Kułak W, Sendrowski K (2010) Anti-inflammatory plasma cytokines in children and adolescents with migraine headaches. Pharmacological Reports 62:287–291CrossRefPubMedGoogle Scholar
  4. Chen M et al (2015) Tumor necrosis factor (TNF)–308G> A, nitric oxide synthase 3 (NOS3)+ 894G> T polymorphisms and migraine risk: a meta-analysis. PLoS One 10:e0129372CrossRefPubMedPubMedCentralGoogle Scholar
  5. Covelli V et al (1991a) Increased spontaneous release of tumor necrosis factor-α/cachectin in headache patients. A possible correlation with plasma endotoxin and hypothalamic-pituitary-adrenal axis. International journal of neuroscience 61:53–60CrossRefPubMedGoogle Scholar
  6. Covelli V et al (1991b) In vivo administration of propranolol decreases exaggerated amounts of serum TNF-alpha in patients with migraine without aura. Possible mechanism of action. Acta neurologica 14:313–319Google Scholar
  7. Cunha F, Poole S, Lorenzetti B, Ferreira S (1992) The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. British journal of pharmacology 107:660–664CrossRefPubMedPubMedCentralGoogle Scholar
  8. de Alcântara GFT et al (2017) Curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia. Journal of Traditional and Complementary Medicine 7:14–23CrossRefPubMedGoogle Scholar
  9. Deverman BE, Patterson PH (2009) Cytokines and CNS development. Neuron 64:61–78CrossRefPubMedGoogle Scholar
  10. Fidan I, Yüksel S, Ýmir T, İrkeç C, Aksakal FN (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171:184–188CrossRefPubMedGoogle Scholar
  11. Franceschini A, Vilotti S, Ferrari MD, Van Den Maagdenberg AM, Nistri A, Fabbretti E (2013) TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PloS one 8:e52394CrossRefPubMedPubMedCentralGoogle Scholar
  12. Ganjali S et al (2014) Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. The Scientific World Journal:2014Google Scholar
  13. Garza I, Swanson JW (2006) Prophylaxis of migraine. Neuropsychiatric disease and treatment 2:281CrossRefPubMedPubMedCentralGoogle Scholar
  14. Gerring ZF, Powell JE, Montgomery GW, Nyholt DR (2017) Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways Cephalalgia:0333102416686769Google Scholar
  15. Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as “curecumin”: from kitchen to clinic. Biochem Pharmacol 75:787–809CrossRefPubMedGoogle Scholar
  16. Harel Z, Gascon G, Riggs S, Vaz R, Brown W, Exil G (2002) Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. Journal of Adolescent Health 31:154–161CrossRefPubMedGoogle Scholar
  17. Haut SR, Bigal ME, Lipton RB (2006) Chronic disorders with episodic manifestations: focus on epilepsy and migraine. The Lancet Neurology 5:148–157CrossRefPubMedPubMedCentralGoogle Scholar
  18. Ji R-R, Xu Z-Z, Strichartz G, Serhan CN (2011) Emerging roles of resolvins in the resolution of inflammation and pain. Trends in Neurosciences 34:599–609CrossRefPubMedPubMedCentralGoogle Scholar
  19. Jia Q et al (2011) Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice. British journal of nutrition 106:519–529CrossRefPubMedPubMedCentralGoogle Scholar
  20. Kanai M et al (2012) Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer chemotherapy and pharmacology 69:65–70CrossRefPubMedGoogle Scholar
  21. Levy D (2010) Migraine pain and nociceptor activation—where do we stand? Headache: The Journal of Head and Face Pain 50:909–916CrossRefGoogle Scholar
  22. Liu R et al (2014) Effects of tumor necrosis factor-β (TNF-β) 252A> G polymorphism on the development of migraine: a meta-analysis. PLoS One 9:e100189CrossRefPubMedPubMedCentralGoogle Scholar
  23. Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurological Sciences 27:s107–s110CrossRefPubMedGoogle Scholar
  24. Malhotra R (2016) Understanding migraine: Potential role of neurogenic inflammation. Annals of Indian Academy of Neurology 19:175CrossRefPubMedPubMedCentralGoogle Scholar
  25. Mirza M et al (2013) Progressive retinal degeneration and glial activation in the CLN6 nclf mouse model of neuronal ceroid Lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PLoS One 8:e75963CrossRefPubMedPubMedCentralGoogle Scholar
  26. Mittal N, Joshi R, Hota D, Chakrabarti A (2009) Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytotherapy Research 23:507–512CrossRefPubMedGoogle Scholar
  27. Mottaghi A, Salehi E, Keshvarz A, Sezavar H, Saboor-Yaraghi A-A (2013) The influence of vitamin A supplementation on Foxp3 and TGF-β gene expression in atherosclerotic patients. Journal of nutrigenetics and nutrigenomics 5:314–326CrossRefGoogle Scholar
  28. Mueller L, Gupta AK, Stein TP (2001) Deficiency of tumor necrosis factor α in a subclass of menstrual migraineurs Headache. The Journal of Head and Face Pain 41:129–137CrossRefGoogle Scholar
  29. Mulder EJ et al (2003) Genetic and environmental influences on migraine: a twin study across six countries. Twin Research 6:422–431CrossRefPubMedGoogle Scholar
  30. Perini F et al (2005) Plasma cytokine levels in migraineurs and controls Headache. The Journal of Head and Face Pain 45:926–931CrossRefGoogle Scholar
  31. Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annual review of physiology 75:365–391CrossRefPubMedGoogle Scholar
  32. Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay J, Biason P (2001) Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia 21:818–822CrossRefPubMedGoogle Scholar
  33. Ramirez-Ramirez V et al. (2013) Efficacy of fish oil on serum of TNFα, IL-1β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxidative medicine and cellular longevity 2013Google Scholar
  34. Sasaki H et al (2011) Innovative preparation of curcumin for improved oral bioavailability. Biological and Pharmaceutical Bulletin 34:660–665CrossRefPubMedGoogle Scholar
  35. Saw CLL, Huang Y, Kong A-N (2010) Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid. Biochemical pharmacology 79:421–430CrossRefPubMedGoogle Scholar
  36. Shehzad A, Lee Y (2010) Curcumin: multiple molecular targets mediate multiple pharmacological actions: a review. Drugs Fut 35:113CrossRefGoogle Scholar
  37. Shehzad A, Rehman G, Lee YS (2013) Curcumin in inflammatory diseases. Biofactors 39:69–77CrossRefPubMedGoogle Scholar
  38. Shishodia S (2013) Molecular mechanisms of curcumin action: gene expression. Biofactors 39:37–55CrossRefPubMedGoogle Scholar
  39. Stovner L et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210CrossRefPubMedGoogle Scholar
  40. Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M (2012) The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial. Iranian Journal of Neurology 11:21PubMedPubMedCentralGoogle Scholar
  41. Tanure MTA, Gomez RS, Hurtado RCL, Teixeira AL, Domingues RB (2010) Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. The journal of headache and pain 11:427–430CrossRefPubMedPubMedCentralGoogle Scholar
  42. Thota RN, Acharya SH, Abbott KA, Garg ML (2016) Curcumin and long-chain omega-3 polyunsaturated fatty acids for prevention of type 2 diabetes (COP-D): study protocol for a randomised controlled trial. Trials 17:565CrossRefPubMedPubMedCentralGoogle Scholar
  43. Ward TN (2012) Migraine diagnosis and pathophysiology . CONTINUUM. Lifelong Learning in Neurology 18:753–763CrossRefPubMedGoogle Scholar
  44. Xu Z-Z et al (2010) Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16:592–597CrossRefPubMedPubMedCentralGoogle Scholar
  45. Yu S et al (2012) The prevalence and burden of primary headaches in China: a population-based door-to-door survey Headache. The Journal of Head and Face Pain 52:582–591CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Mina Abdolahi
    • 1
  • Abbas Tafakhori
    • 2
  • Mansoureh Togha
    • 3
  • Ali Asghar Okhovat
    • 3
  • Feridoun Siassi
    • 4
  • Mohammad Reza Eshraghian
    • 5
  • Mohsen Sedighiyan
    • 6
  • Mona Djalali
    • 7
  • Niyaz Mohammadzadeh Honarvar
    • 1
  • Mahmoud Djalali
    • 1
  1. 1.Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and DieteticsTehran University of Medical SciencesTehranIran
  2. 2.Iranian Centre of Neurological Research, Department of Neurology, Imam Khomeini HospitalTehran University of Medical SciencesTehranIran
  3. 3.Headache Department, Iranian Center of Neurological Research, Neuroscience InstituteTehran University of Medical SciencesTehranIran
  4. 4.Department of Community Nutrition, School of Nutritional Sciences and DieteticsTehran University of Medical SciencesTehranIran
  5. 5.Department of Biostatistic, School of Public HealthTehran University of Medical SciencesTehranIran
  6. 6.Department of Clinical Nutrition, School of Nutritional Sciences and DieteticsTehran University of Medical SciencesTehranIran
  7. 7.Department of Molecular Genetics, Faculty of Biological SciencesTarbiat Modares UniversityTehranIran

Personalised recommendations